Sarah’s expertise will be instrumental in helping us advance our mission of bringing potentially transformational TCR-T’s to patients – Neogene Therapeutics

Neogene Therapeutics announced on their LinkedIn:

“Today, we are spotlighting one of our exceptional new leaders at Neogene, Sarah Cohen, Vice President of Clinical Development. With over 16 years of clinical and industry experience in developing much-needed treatments, including those for cancer, Sarah’s expertise will be instrumental in helping us advance our mission of bringing potentially transformational TCR-T’s to patients.”

Source: Neogene Therapeutics/LinkedIn